Weber J, Mandala M, Del Vecchio M, et al. Adjuvant therapy witz nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage III/IV melanoma: a randomized, double-blind, phase 3 trial (CheckMate 238). ESMO 2017 Congress; abstract LBA8_PR.,Weber J, Mandala M, Del Vecchio M, et al. Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma. N Engl J Med. DOI: 10.1056/NEJMoa1709030.
Zelfmoordcijfers hoog onder longkankerpatiënten
jun 2017 | Longoncologie